SYNPRED: prediction of drug combination effects in cancer using different synergy metrics and ensemble learning.

ABSTRACT:

Background

In cancer research, high-throughput screening technologies produce large amounts of multiomics data from different populations and cell types. However, analysis of such data encounters difficulties due to disease heterogeneity, further exacerbated by human biological complexity and genomic variability. The specific profile of cancer as a disease (or, more realistically, a set of diseases) urges the development of approaches that maximize the effect while minimizing the dosage of drugs. Now is the time to redefine the approach to drug discovery, bringing an artificial intelligence (AI)-powered informational view that integrates the relevant scientific fields and explores new territories.

Results

Here, we show SYNPRED, an interdisciplinary approach that leverages sp

SUBMITTER: Preto AJ 

PROVIDER: S-EPMC9511701 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature